TABLE 2.

Fatty acid composition of 16HBE cells cultured in 10% horse serum lot A

	WT	CF
	Mol%a
Saturated
16:0	16.95 ± 0.70	18.90 ± 0.80
18:0	16.35 ± 0.95	17.93 + 0.65
20:0	0.36 ± 0.06	0.17 ± 0.01c
22:0	0.11 ± 0.02	0.08 ± 0.02
24:0	0.40 ± 0.14	0.06 ± 0.06
n-6
18:2n-6	17.20 ± 0.91	12.61 ± 0.96c
18:3n-6	0.25 ± 0.04	0.35 ± 0.05
20:2n-6	0.61 ± 0.06	0.15 ± 0.04d
20:3n-6	1.22 ± 0.13	1.21 ± 0.15
20:4n-6	11.14 ± 0.59	14.82 ± 0.62c
22:4n-6	2.51 ± 0.17	1.39 ± 0.12d
22:5n-6	1.34 ± 0.33	0.08 ± 0.04c
n-3
18:3n-3	ND	ND
20:5n-3	0.15 ± 0.04	0.66 ± 0.09d
22:5n-3	2.68 ± 0.18	3.28 ± 0.41
22:6n-3	0.91 ± 0.19	0.37 ± 0.13b
n-7
16:1n-7	2.88 ± 0.40	3.11 ± 0.44
18:1n-7	3.37 ± 0.19	2.52 ± 0.13c
n-9
18:1n-9	19.73 ± 0.60	20.45 ± 1.26
20:1n-9	0.24 ± 0.03	0.05 ± 0.01d
20:3n-9	0.27 ± 0.10	0.24 ± 0.14

WT, wild-type; CF, cystic fibrosis. Data are given as mean ± SEM.

^aMol% = mol% of total fatty acids.

^bP < 0.05 comparing WT cells with CF cells.

^cP < 0.01 comparing WT cells with CF cells.

^dP < 0.001 comparing WT cells with CF cells.